.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
UBS
Boehringer Ingelheim
US Army
Chubb
Covington
Dow
Accenture
Baxter

Generated: November 22, 2017

DrugPatentWatch Database Preview

Claims for Patent: 8,450,338

« Back to Dashboard

Claims for Patent: 8,450,338

Title:Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof
Abstract: Compositions are provided that are useful for the preparation of a medicament. The compositions comprise granules having a layer of sodium picosulphate coated on potassium bicarbonate. Additional granules having a layer of magnesium oxide coated on a core of citric acid are also provided. The two types of granules may be combined to obtain mixtures (preferably homogeneous or substantially homogeneous mixtures) of the two types of granules, which are useful, e.g., as pharmaceutical compositions.
Inventor(s): Xu; Haijun (Zhongshan, CN), Diao; Tiejun (Zhongshan, CN)
Assignee: Ferring International Center S.A. (St-Prex, CH)
Application Number:13/246,739
Patent Claims: 1. A composition comprising sodium picosulphate coated granules having a spray-coated layer of sodium picosulphate coating a potassium bicarbonate core.

2. The composition according to claim 1, wherein the granules have a diameter between about 100 .mu.m and about 900 .mu.m.

3. The composition according to claim 1 wherein more than 85% of the granules have a diameter between about 100 .mu.m and about 900 .mu.m.

4. The composition according to claim 1 wherein less than 5% of the granules have a diameter greater than about 900 .mu.m; or wherein less than 5% of the granules have a diameter less than about 100 .mu.m.

5. The composition according to claim 1 which is a pharmaceutical composition.

6. The composition according to claim 1, further comprising a dry mixture of citric acid and magnesium oxide.

7. A composition prepared by a process comprising steps of: (a) spray coating a solution of sodium picosulphate onto potassium bicarbonate; and (b) drying the sodium picosulphate and potassium bicarbonate thereby obtaining sodium picosulphate-coated granules, wherein the sodium picosulphate-coated granules have a layer of sodium picosulphate coating a potassium bicarbonate core.

8. A process for the preparation of a composition according to claim 1 wherein said process comprises steps of: (a) spray coating a solution of sodium picosulphate on to potassium bicarbonate; and (b) drying the sodium picosulphate and potassium bicarbonate thereby obtaining sodium picosulphate coated granules, wherein the sodium picosulphate coated granules have a layer of sodium picosulphate coating a potassium bicarbonate core.

9. The process according to claim 8 wherein the potassium bicarbonate is preheated prior to spray coating the solution of sodium picosulphate on to the potassium bicarbonate.

10. The process according to claim 8 wherein the sodium picosulphate and potassium bicarbonate are dried at a temperature of between 30.degree. to 100.degree. C.

11. The process according to claim 8 wherein the step of drying is performed during or after the step of spray coating.

12. The process according to claim 11, wherein the step of drying is performed immediately after the step of spray coating.

13. The process according to claim 8 wherein the steps of spray coating and drying are each applied two or more times, and wherein each step of drying is performed during or after a step of spray coating.

14. The process according to claim 13, wherein each step of drying is performed immediately after a step of spray coating.

15. The process according to claim 8 wherein the sodium picosulphate coated granules have a particle diameter between about 100 .mu.m and about 900 .mu.m.

16. The process according to claim 8 wherein more than 85% of the sodium picosulphate coated granules have a diameter between about 100 .mu.m and about 900 .mu.m.

17. The process according to claim 8 wherein less than 5% of the sodium picosulphate coated granules have a diameter greater than about 900 .mu.m; or wherein less than 5% of the sodium picosulphate coated granules have a diameter less than about 100 .mu.m.

18. The process according to claim 8 wherein the sodium picosulphate is in aqueous solution.

19. The process according to claim 8, which additionally comprises mixing at least a part of the sodium picosulphate coated granules with: (i) a dry mixture of citric acid and magnesium oxide, and (ii) optionally, at least one of saccharin sodium and orange flavoring.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Moodys
Dow
US Army
US Department of Justice
QuintilesIMS
Argus Health
AstraZeneca
Medtronic
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot